High-Risk IV Medications in Special Patient Populations
(Sprache: Englisch)
Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are...
Jetzt vorbestellen
versandkostenfrei
Buch (Gebunden)
109.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „High-Risk IV Medications in Special Patient Populations “
Klappentext zu „High-Risk IV Medications in Special Patient Populations “
Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
Inhaltsverzeichnis zu „High-Risk IV Medications in Special Patient Populations “
Anesthetic agents (general, inhaled, intravenous).- Propofol, ketamine, etc.- Anti-infectives.- aminoglycosides, vancomycin, drotrecogin, amphotericin products.- inhaled agents.- Anticoagulants agents.- unfractionated heparin, low molecular weight heparins, fondaparinux, lepirudin, argatroban, bivalrudin, abciximab, eptifibatide, tirofiban.- Thrombolytics -reteplase, tenecteplase, streptokinase, urokinase, alteplase.- Cardiac Drugs.- Adrenergic agents.- dopamine, dobutamine, vasopressin, , nitroglycerin, nitroprusside epinephrine, norepinepherine, phenylepherine.- Adrenergic antagonists.- Propranolol, diltiazem, verapamil, esmolol, labetalol, clevidipine.- Antidyrrhthmics.- amiodarone, lidocaine, procainamide.- Inotropic agents.- milrinone, amrinone, isoproterenol, niseritide, digoxin.- Prostanoids.- Epoprostenol, iloprost, treprostenil.- Electrolytes.- Potassium, magnesium, sodium chloride (hypertonic), cardioplegic solutions.- Hypoglycemics.- Insulin and oral agents.- Neuromuscular blocking agents .- vecuronium, rocuronium, cisatracurium, atracurium, succinylcholine.- Opioids (IV, oral).- Remifentanyl, fentanyl , morphine, hydromorphone, meperidine.- Sedatives (IV, oral and transdermal).- lorazepam, midazolam, diazepam, propofol, dexmedetomidine.- Information for Each Drug.- Propofol .- Normal.- Obese.- Renal Dysfunction.- CrCL.- Dialysis (HD, CRRT).- Liver Dysfunction.- Recommendations for Safe Use.
Bibliographische Angaben
- 2011, 2011, X, 160 Seiten, Maße: 16 x 24,1 cm, Gebunden, Englisch
- Herausgegeben: Sandra Kane-Gill, Joseph Dasta
- Verlag: Springer, Berlin
- ISBN-10: 0857296051
- ISBN-13: 9780857296054
- Erscheinungsdatum: 29.06.2011
Sprache:
Englisch
Rezension zu „High-Risk IV Medications in Special Patient Populations “
From the reviews:"This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. ... It is intended for clinicians treating critically ill patients with high-risk intravenous medications. This is a good reference for doctors, nurses, pharmacists, and students in these disciplines to use to become well versed in the safe use of dangerous medications. ... This is an excellent book that provides clear, concise information in a very usable format." (Judith Klevan, Doody's Review Service, November, 2011)
Pressezitat
From the reviews:"This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. ... It is intended for clinicians treating critically ill patients with high-risk intravenous medications. This is a good reference for doctors, nurses, pharmacists, and students in these disciplines to use to become well versed in the safe use of dangerous medications. ... This is an excellent book that provides clear, concise information in a very usable format." (Judith Klevan, Doody's Review Service, November, 2011)
Kommentar zu "High-Risk IV Medications in Special Patient Populations"
Schreiben Sie einen Kommentar zu "High-Risk IV Medications in Special Patient Populations".
Kommentar verfassen